TargED Biopharmaceuticals has completed the second closing of its Series A2 financing round.

Deal: TargED Biopharmaceuticals has successfully completed the second closing of its Series A2 financing round, raising €40.4 million. This brings the total Series A financing to more than €80 million.

Value: $80 million

Sector: technology 

Date: 1 July 2026

Barbara Strozzilaan 362
Eurocenter II, 4th floor
1083 HN Amsterdam

info@elementslegal.com

CC 63814773
VAT NL.8554.12.859.B01

Expertise

Team

Contact

© 2025 Elements Legal. All rights reserved.

Barbara Strozzilaan 362
Eurocenter II, 4th floor
1083 HN Amsterdam

info@elementslegal.com

CC 63814773
VAT NL.8554.12.859.B01

Expertise

Team

Contact

© 2025 Elements Legal. All rights reserved.

Barbara Strozzilaan 362
Eurocenter II, 4th floor
1083 HN Amsterdam

info@elementslegal.com

CC 63814773
VAT NL.8554.12.859.B01

Expertise

Team

Contact

© 2025 Elements Legal. All rights reserved.